Annual Drug Patent Expirations for NEUPRO
Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for NEUPRO.
This drug has one hundred and forty-three patent family members in thirty-eight countries.
The generic ingredient in NEUPRO is rotigotine. One supplier is listed for this compound. Additional details are available on the rotigotine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
